[Pulmonary tuberculosis in 1996. Recent data and practical consequences for the anesthesiologist]

Area of Science:

• Medicine
• Infectious Diseases
• Public Health

Background:

• Tuberculosis remains a significant global health challenge, causing millions of deaths annually.
• Industrialized nations have observed a resurgence in tuberculosis incidence over the past decade.
• Human Immunodeficiency Virus (HIV) infection is a primary driver of increased tuberculosis cases and mortality.

Purpose of the Study:

• To highlight the increasing incidence of tuberculosis, especially in industrialized countries.
• To emphasize the link between HIV infection and tuberculosis, including multidrug-resistant strains.
• To discuss the risks of nosocomial tuberculosis transmission and the importance of preventive measures.

Main Methods:

• Review of epidemiological data on tuberculosis incidence and mortality.
• Analysis of the impact of HIV co-infection on tuberculosis presentation and treatment.
• Examination of airborne transmission routes and nosocomial outbreak potential.
• Assessment of potential drug interactions and toxicities, particularly hepatic toxicity with anesthetic agents.

Main Results:

• Tuberculosis affects over eight million people globally, with approximately three million deaths annually.
• HIV infection is a major factor contributing to the rise in tuberculosis cases and mortality.
• Nosocomial outbreaks of tuberculosis have been documented among healthcare workers and patients, often involving multidrug-resistant strains.

Conclusions:

• Physicians must be vigilant regarding the increased risk of tuberculosis, especially in HIV-infected populations.
• Strict adherence to infection control guidelines, including respiratory isolation, is essential to prevent nosocomial transmission.
• Potential hepatic toxicity from antitubercular drugs in combination with anesthetic agents requires careful consideration.